Alternative

CEO & Founder Cort Smith of Da Vinci Vaporizer to Be Interviewed Live on Clear Channel''s "The Trader''s Network Show"

LAS VEGAS, NV: Live Interview to Air February 28th 2015 Hosted by Michael Yorba, 1:30pm ET/10:30am PT/12:30pm CT ...

Noted HIT Thought Leader Justin Barnes Takes on Advisory Role With ePatientFinder, the EHR-Driven Patient Recruitment Solution

AUSTIN, TX and ATLANTA, GA: ...

BioSyent Releases Q4 and Full Year 2014 Results - Full Year Sales Up 57%; Pharma Sales Up 63%; Net Income Up 64%; Diluted EPS $0.22 Up 69%; Cash and Short-Term Investments $8.0 Million Up 82%

TORONTO, ONTARIO: ...

Pre-Clinical Animal Pilot Study Shows Arch Therapeutics'' AC5(TM) Compared Favorably Versus a Popular Hemostatic Agent

WELLESLEY, MA: Data Show Time to Hemostasis With AC5 Significantly Less Than Compared Product ...

Health Canada Grants Aurora MMPR License

VANCOUVER, BRITISH COLUMBIA: ...

CEN Biotech Inc. Shareholder Update

BEVERLY HILLS, CA: ...

Nanomedicine: Nanotechnology, Biology, and Medicine Publishes Preclinical Data on Arch Therapeutics'' AC5 Surgical Hemostatic Device(TM)

WELLESLEY, MA: Independent Peer-Reviewed Study Concludes That AC5(TM) Quickly Stops Bleeding in Animals Treated With the Anticoagulant, Heparin ...

The British Standards Institution Classifies Arch Therapeutics'' AC5(TM) as a Medical Device Within the European Union

WELLESLEY, MA: AC5 Surgical Hemostatic Device(TM) Fulfills Definition of a Medical Device CE Mark Designation ...

Response Biomedical Corp. Announces Milestone Achievement in Co-Development Collaboration

VANCOUVER, BRITISH COLUMBIA: ...

Mettrum Announces Third Quarter 2014 Financial Results

TORONTO, ONTARIO: ...